Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity
Cell Death Discov. 2024 Sep 30;10(1):417. doi: 10.1038/s41420-024-02184-z.ABSTRACTFatty…
Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity
Cell Death Discov. 2024 Sep 30;10(1):417. doi: 10.1038/s41420-024-02184-z.ABSTRACTFatty…
Oxygen matters: Unraveling the role of oxygen in the neuronal response to cisplatin
J Peripher Nerv Syst. 2024 Sep 27. doi: 10.1111/jns.12659. Online…
BET inhibitors down-regulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1
Haematologica. 2024 Sep 26. doi: 10.3324/haematol.2024.285966.…
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
Leukemia. 2024 Sep 25. doi: 10.1038/s41375-024-02410-8. Online…
What is chemical biology?
Cell Chem Biol. 2024 Sep 19;31(9):1562-1565. doi: 10.1016/j.chembiol.2024.08.011.ABSTRACTSince…
Deletion of the RGD motif from the penton base in oncolytic adenoviruses enhances antitumor efficacy of combined CAR T cell therapy
Mol Ther Oncol. 2024 Aug 23;32(3):200863. doi: 10.1016/j.omton.2024.200863.…
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
Lancet. 2024 Sep 13:S0140-6736(24)01653-2. doi: 10.1016/S0140-6736(24)01653-2.…
Measurable Residual Disease by Mass Spectrometry and Next-Generation Flow to Assess Treatment Response in Myeloma
Blood. 2024 Sep 18:blood.2024024995. doi: 10.1182/blood.2024024995.…
Combining Data-Driven and Structure-Based Approaches in Designing Dual PARP1-BRD4 Inhibitors for Breast Cancer Treatment
J Chem Inf Model. 2024 Sep 18. doi: 10.1021/acs.jcim.4c01421.…
Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma
Cancers (Basel). 2024 Sep 1;16(17):3053. doi: 10.3390/cancers16173053.ABSTRACTUveal…
Proceedings from the First Onco Summit: LATAM Chapter, 19-20 May 2023, Rio de Janeiro, Brazil
Cancers (Basel). 2024 Sep 3;16(17):3063. doi: 10.3390/cancers16173063.ABSTRACTThe…
